Searchable abstracts of presentations at key conferences in endocrinology

ea0068p8 | Abstracts | UKINETS2019

Audit of the appropriateness and outcomes of 24-hour urinary 5-HIAA testing in a UK general hospital

Higginson Kieren , Pritchard D Mark

Introduction: Some functional neuroendocrine tumours (NETs) secrete serotonin, leading to the symptoms of carcinoid syndrome (e.g. diarrhoea and flushing). In this condition, increased urinary concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) are often detected. Measurement of 24-hour urinary 5-HIAA is therefore used to investigate patients with confirmed or suspected carcinoid syndrome. We sought to evaluate the appropriateness and effectiveness o...

ea0055cb10 | Additional Cases | SFEEU2018

A 60 year history of recurrent hypoglycaemia

Foteinopoulou Evgenia , Colclough Kevin , Strachan Mark

A 69 year old male was referred with a 60 year history of recurrent hypoglycaemia. Over the previous 12 months he had several episodes of severe hypoglycaemia, which necessitated emergency treatment from paramedics. He had been diagnosed with a hypoglycaemic disorder at the age of 9 years, but no underlying cause had been identified. He had no other previous history of note, though he was macrosomic at birth with a birth weight of approximately 5.9 kg. His mother was diagnosed...

ea0052p07 | (1) | UKINETS2017

Piloting a group programme aiming at psychologically supporting neuroendocrine patients

Southern Mark , Ainsbury Karen , Bayne Mike

Background: The median survival for patients with metastatic neuroendocrine tumours is greater than 5 years. Despite a heavy burden of metastatic disease and an incurable diagnosis many patients continue with a relatively normal lifestyle. Vast amounts of time and money is spent on diagnosing and treating the physical aspects of cancer but little is currently available to help with the psychological wellbeing of our patients. As NET nurses we spend large amounts of our time ta...

ea0050p025 | Adrenal and Steroids | SFEBES2017

Epidemiology of PPGLs – A population based approach

Imbroll Miriam Giordano , Vassallo Josanne , Gruppetta Mark

Phaeochromocytoma/paragangliomas (PPGLs) are relatively rare tumours and the health burden of such tumours is not very well known.Aim: This population based study aims to characterise all the phaeochromocytomas, paragangliomas and adrenal medullary hyperplasia diagnosed between 2007 and 2016 in Malta; looking into presentation, hormonal analysis, imaging characteristics and histology findings.Results: 16 ...

ea0050p025 | Adrenal and Steroids | SFEBES2017

Epidemiology of PPGLs – A population based approach

Imbroll Miriam Giordano , Vassallo Josanne , Gruppetta Mark

Phaeochromocytoma/paragangliomas (PPGLs) are relatively rare tumours and the health burden of such tumours is not very well known.Aim: This population based study aims to characterise all the phaeochromocytomas, paragangliomas and adrenal medullary hyperplasia diagnosed between 2007 and 2016 in Malta; looking into presentation, hormonal analysis, imaging characteristics and histology findings.Results: 16 ...

ea0082oc4 | Oral Communications | SFEEU2022

Barakat syndrome: A rare cause of primary hypoparathyroidism

Mark-Wagstaff Charlotte , Sathyapalan Thozhukat , Deshmukh Harshal

Case history: A 54-year-old lady was diagnosed with primary hypoparathyroidism in 2006, after being referred by her Rheumatologist as her father and brother had familial hypoparathyroidism and sensorineural deafness. She was followed up in endocrine clinic for management of primary hypoparathyroidism. Her hypocalcaemia is well managed with calcium supplementation, with no specific symptoms of hypocalcaemia. She has recurrent urinary tract infections with known borderline chro...

ea0086p73 | Metabolism, Obesity and Diabetes | SFEBES2022

The Unusual Suspects: Steroid receptors & hormones found in the mitochondria

Younis Awais , Christian Mark , Doig Craig

Appreciation of hormonal control over mitochondrial function has increased over recent decades. Mitochondria adapt to the cellular environment through a variety of mechanisms; mitochondrial dynamics (fusion, fission, transfer) or through the signalling of a variety of proteins to induce mitophagy, depending on the cell stressor. In parallel, nuclear receptors and the production of their steroid hormone ligands within mitochondria have been a reoccurring incidental measurement....

ea0090rc7.2 | Rapid Communications 7: Pituitary and Neuroendocrinology 2 | ECE2023

Transcription factor analysis for pituitary tumours: Are results always consistent and reliable?

Fookeerah Prishila , Varikatt Winny , McLean Mark

Background: Improved diagnostic precision is achieved with the addition of transcription factor (TF) analysis to characterise pituitary tumours. Clinicopathological studies have demonstrated a reduction in the prevalence of true null cell tumours (NC) and a rise in plurihormonal (PH) tumours, in comparison to methods based on hormone staining. There remains a high degree of heterogeneity in epidemiological and clinical patterns seen in studies. We hypothesise that variations i...

ea0090p131 | Pituitary and Neuroendocrinology | ECE2023

Somatostatin receptor expression in pituitary tumours according to the 2022 WHO classification: An insight into the rarer morphological subtypes

Fookeerah Prishila , Varikatt Winny , McLean Mark

Introduction: Pituitary tumours may express somatostatin receptors (SSTR), which are a potential drug target to achieve tumour reduction and control of hormone secretion. There is a well-established role for somatostatin analogues in the management of acromegaly and Cushing’s disease. The recent 2022 WHO classification of pituitary tumours provides a comprehensive approach to the diagnosis of pituitary tumours, allowing identification of additional morphological subtypes....

ea0090p160 | Pituitary and Neuroendocrinology | ECE2023

Multimodal therapy for the management of an aggressive corticotroph tumour after bilateral adrenalectomy

Fookeerah Prishila , Varikatt Winny , McLean Mark

Background: Rapid progression of corticotroph tumours can occur after bilateral adrenalectomy for treatment of Cushing’s disease. There are currently no guidelines to assist with management of aggressive cases of Nelson’s syndrome, particularly after surgery and radiotherapy.Clinical case: A 53 year old woman presented with classic clinical features of hypercortisolism. Initial investigations showed a markedly elevated 24 hour urine cortisol le...